July 17, 2026
3 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Pegcetacoplan slows photoreceptor and retinal pigment epithelium loss in patients with geographic atrophy only as well as patients with GA and concurrent wet age-related macular degeneration, according to a speaker.At the American Society of Retina Specialists annual meeting. Hasenin Al-khersan, MD, presented findings from a retrospective study of 240 eyes of 199 patients using data from the
July 17, 2026
3 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

MONTREAL — Pegcetacoplan may help slow visual acuity loss in patients with geographic atrophy, according to a study presented at…

In this video, Sunir J. Garg, MD, FACS, FASRS, talked about a post hoc analysis of pegcetacoplan clinical trials in geographic…

Largest effects seen in eyes with GA and AMD, dual treatment with pegcetacoplan, VEGF inhibitor

CG-P5, a topical peptide eye drop, met safety and efficacy endpoints for wet age-related macular degeneration, according to a…

DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual…

MONTREAL — In a phase 2b study, an intravitreal gene therapy reduced the treatment burden in patients with neovascular…